Travere Therapeutics (TVTX)
(Delayed Data from NSDQ)
$26.85 USD
+0.71 (2.72%)
Updated Oct 15, 2025 04:00 PM ET
After-Market: $26.86 +0.01 (0.04%) 7:58 PM ET
2-Buy of 5 2
F Value A Growth F Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Travere Therapeutics, Inc. has a market cap of $2.33B, which represents its share price of $26.14 multiplied by its outstanding shares number of 89.14M. As a mid-cap company, TVTX's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TVTX 26.85 +0.71(2.72%)
Will TVTX be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for TVTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TVTX
What Makes Travere (TVTX) a New Strong Buy Stock
Will Livmarli Continue to Drive Mirum's Top Line in Q3 Earnings?
TVTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
TVTX Stock Soars as FDA Waives Advisory Committee for Filspari sNDA
Strength Seen in Travere (TVTX): Can Its 26.2% Jump Turn into More Strength?
Here's What Key Metrics Tell Us About Travere (TVTX) Q2 Earnings
Other News for TVTX
Is TVTX consolidating before a move? NR7 shows up after dropping 0.23%
180 Bullish Setup appears for TVTX after 4.13% move
Is TVTX consolidating before a move? NR7 shows up after sinking 3.49%
TVTX forms Shooting Star Candlestick on October 9
TVTX forms 180 Bullish Setup on October 8